Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins
Diabetes mellitus increases the risk of tuberculosis (TB) disease and adverse TB outcomes [1]. Emerging evidence suggests diabetes is also associated with latent TB infection (LTBI), and population-based studies reported the prevalence of LTBI among US adults with diabetes to be more than twice that of adults without diabetes (11.6% versus 4.6%) [2, 3]. Given the rapid increase of global diabetes prevalence in regions with high TB burdens, clinical and public health interventions targeting this co-epidemic would avert substantial morbidity and mortality [4].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Magee, M. J., Salindri, A. D., Kornfeld, H., Singhal, A. Tags: Original Articles: Research letters Source Type: research
More News: Cholesterol | Diabetes | Diabetes Mellitus | Endocrinology | Epidemics | Epidemiology | Fortamet | International Medicine & Public Health | Metformin | Respiratory Medicine | Statin Therapy | Study | Tuberculosis